Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article

IMJ. 2015; 7(4): 220-224


CLINICAL SPECTRUM OF CHRONIC KIDNEY DISEASE: A STUDY OF 50 PATIENTS AT LUMHS

SONIHA ASLAM, ASLAM GHOURI, ANIL KUMAR, SHAHZAMAN KHAN, YASMEEN IQBAL.

Abstract
OBJECTIVE: To evaluate different clinical presentations of chronic kidney disease (CKD) and to raise the index of clinical suspicion so to diagnose and treat CKD at the earliest.
STUDY DESIGN: A cross sectional observational study.
PLACE AND DURATION: Medical unit III, Liaquat University hospital, Jamshoro from 1 Apr – 30 Sep'2014.
METHODOLOGY: We studied fifty patients of CKD, diagnosed by standard clinical criteria. A self administered questionnaire was used to record patient's history and clinical examination. Complete blood count, urine analysis, urea, creatinine, electrolytes, sugar, calcium, spot urine albumin to creatinine ratio and renal ultrasound were done in every patient. In selected cases, renal biopsy was also done.
RESULTS: Out of 50 patients, 62% (n = 31) were men, a mean age of 46.22 years (± 12.89 SD), a mean creatinine clearance of 5 mmol/24 hours (±2.16 SD), a mean albumin: creatinine ratio of 49 mg/g (±11.33 SD) and a mean serum creatinine of 16.5 mg/dl (±6.65 SD). Chronic glomerulonephritis (30%), hypertension (24%) and diabetic nephropathy (20%) were the leading causes of CKD. Anemia (94%) was universal finding on laboratory work up. Gastrointestinal manifestations stand out among the clinical presentations with anorexia (76%), nausea (60%) vomiting (40%) and abdominal pain (26%).
CONCLUSION: We observed that gastrointestinal disturbances are the commonest clinical presentations in CKD along with anemia, fatigue, dyspnea, hiccups, itching, hypertension and edema. Early diagnosis and management of CKD may prevent or delay the progress to end stage renal disease.

Key words: Chronic kidney disease, Glomerulonephritis, Hypertension, Diabetes, Gastrointestinal manifestations.



Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

Dendritic spine density changes and homeostatic synaptic scaling: a meta-analysis of animal studies.
Moulin TC, Rayêe D, Schiöth HB
Neural regeneration research. 2022; 17(1): 20-24


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites